Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among elderly adults during the 2010-2011 season

Clinical Infectious Diseases

Volumn 57, Issue 6, 2013, Pages 820-827

  Kwong, Jeffrey C ^a,b,c,e,f   Campitelli, Michael A ^a   Gubbay, Jonathan B ^d,e,g,h   Peci, Adriana ^e   Winter, Anne Luise ^e   Olsha, Romy ^e   Turner, Robert ^a   Rosella, Laura C ^a,e   Crowcroft, Natasha S ^c,d,e  

^a INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^b Department of Family and Community Medicine ^*  (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e PUBLIC HEALTH ONTARIO   (Canada)

^f UNIVERSITY HEALTH NETWORK   (Canada)

^g MOUNT SINAI HOSPITAL   (United States)

^h HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

elderly adults; hospitalization; influenza vaccine; vaccine effectiveness

Indexed keywords

INFLUENZA VACCINE;

AGED; ARTICLE; BILLING AND CLAIMS; CANADA; COMMUNITY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; GROUPS BY AGE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA B; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; SEASONAL INFLUENZA; SEX DIFFERENCE;

ELDERLY ADULTS; HOSPITALIZATION; INFLUENZA VACCINE; VACCINE EFFECTIVENESS;

AGE FACTORS; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HOSPITALIZATION; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; LOGISTIC MODELS; MALE; ONTARIO;

EID: 84883226065     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit404     Document Type: Article

References (38)

1. Thompson WW, Shay DK, Weintraub E, et al. Influenza-associated hospitalizations in the United States. JAMA 2004; 292:1333-40.
2. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003; 289:179-86.
3. van Essen GA, Palache AM, Forleo E, Fedson DS. Influenza vaccination in 2000: recommendations and vaccine use in 50 developed and rapidly developing countries. Vaccine 2003; 21:1780-5.
4. Fiore AE, Uyeki TM, Broder K, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 2010; 59 (RR-8):1-62.
5. National Advisory Committee on Immunization (NACI). Statement on seasonal trivalent inactivated influenza vaccine (TIV) for 2010-2011. Canadian Communicable Disease Report 2010; 36(ACS-6): 1-49.
6. Govaert TM, Thijs CT, Masurel N, Sprenger MJ, Dinant GJ, Knottnerus JA. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA 1994; 272: 1661-5.
7. De Villiers PJ, Steele AD, Hiemstra LA, et al. Efficacy and safety of a live attenuated influenza vaccine in adults 60 years of age and older. Vaccine 2009; 28:228-34.
8. Petrie JG, Ohmit SE, Johnson E, Cross RT, Monto AS. Efficacy studies of influenza vaccines: effect of end points used and characteristics of vaccine failures. J Infect Dis 2011; 203:1309-15.
9. Jefferson T, Di PC, Al-Ansary LA, Ferroni E, Thorning S, Thomas RE. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev 2010; CD004876.
10. Simonsen L, Reichert TA, Viboud C, Blackwelder WC, Taylor RJ, Miller MA. Impact of influenza vaccination on seasonal mortality in the US elderly population. Arch Intern Med 2005; 165:265-72.
11. Jackson LA, Jackson ML, Nelson JC, Neuzil KM,Weiss NS. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol 2006; 35:337-44.
12. Campitelli MA, Rosella LC, Stukel TA, Kwong JC. Influenza vaccination and all-cause mortality in community-dwelling elderly in Ontario, Canada, a cohort study. Vaccine 2010; 29:240-6.
13. Wong K, Campitelli MA, Stukel TA, Kwong JC. Estimating influenza vaccine effectiveness in community-dwelling elderly patients using the instrumental variable analysis method. Arch Intern Med 2012; 172:484-91.
14. Simonsen L, Taylor RJ, Viboud C, Miller MA, Jackson LA. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis 2007; 7:658-66.
15. Orenstein EW, De SG, Haber MJ, et al. Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol 2007; 36:623-31.
16. Jackson ML, Nelson JC. The test-negative design for estimating influenza vaccine effectiveness. Vaccine 2013; 31:2165-8.
17. Belongia EA, Kieke BA, Donahue JG, et al. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. J Infect Dis 2009; 199: 159-67.
18. van Elden LJ, Nijhuis M, Schipper P, Schuurman R, van Loon AM. Simultaneous detection of influenza viruses A and B using real-time quantitative PCR. J Clin Microbiol 2001; 39:196-200.
19. Juurlink D, Preyra C, Croxford R, et al. Canadian Institute for Health Information Discharge Abstract Database: a validation study. Toronto, Canada: Institute for Clinical Evaluative Sciences, 2006.
20. Chan B. Supply of physicians' services in Ontario. Toronto, Canada: Institute for Clinical Evaluative Sciences, 1999.
21. Kwong JC, Manuel DG. Using OHIP physician billing claims to ascertain individual influenza vaccination status. Vaccine 2007; 25: 1270-4.
22. Iron K, Zagorski BM, Sykora K, Manuel DG. Living and dying in Ontario: an opportunity for improved health information. ICES Investigative Report. Toronto, Canada: Institute for Clinical Evaluative Sciences, 2008.
23. Finkelstein MM. Ecologic proxies for household income: how well do they work for the analysis of health and health care utilization? Can J Public Health 2004; 95:90-4.
24. Levy AR, O'Brien BJ, Sellors C, Grootendorst P, Willison D. Coding accuracy of administrative drug claims in the Ontario Drug Benefit database. Can J Clin Pharmacol 2003; 10:67-71.
25. Bronskill SE, Carter MW, Costa AP, et al. Aging in Ontario: an ices chartbook of health service use by older adults. Toronto, Canada: Institute for Clinical Evaluative Sciences, 2010.
26. Starfield B, Weiner J, Mumford L, Steinwachs D. Ambulatory care groups: a categorization of diagnoses for research and management. Health Serv Res 1991; 26:53-74.
27. Scales DC, Guan J, Martin CM, Redelmeier DA. Administrative data accurately identified intensive care unit admissions in Ontario. J Clin Epidemiol 2006; 59:802-7.
28. Treanor JJ, Talbot HK, Ohmit SE, et al. Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains. Clin Infect Dis 2012; 55:951-9.
29. Kissling E, Valenciano M, Cohen JM, et al. I-MOVE multi-centre case control study 2010-11: overall and stratified estimates of influenza vaccine effectiveness in Europe. PLoS One 2011; 6:e27622.
30. Talbot HK, Griffin MR, Chen Q, Zhu Y, Williams JV, Edwards KM. Effectiveness of seasonal vaccine in preventing confirmed influenzaassociated hospitalizations in community dwelling older adults. J Infect Dis 2011; 203:500-8.
31. Castilla J, Martinez-Artola V, Salcedo E, et al. Vaccine effectiveness in preventing influenza hospitalizations in Navarre, Spain, 2010-2011: cohort and case-control study. Vaccine 2012; 30: 195-200.
32. Kissling E, Valenciano M, Larrauri A, et al. Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre casecontrol study. Euro Surveill 2013; pii:20390.
33. Baxter R, Ray GT, Fireman BH. Effect of influenza vaccination on hospitalizations in persons aged 50 years and older. Vaccine 2010; 28:7267-72.
34. Skowronski DM, Janjua NZ, De SG, et al. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season. Clin Infect Dis 2012; 55:332-42.
35. Ferdinands JM, Belongia EA, Nwasike C, Shay DK. Influenza vaccination status is not associated with influenza testing among children: implications for observational studies of vaccine effectiveness. Vaccine 2011; 29:1935-40.
36. Cowling BJ, Fang VJ, Nishiura H, et al. Increased risk of noninfluenza respiratory virus infections associated with receipt of inactivated influenza vaccine. Clin Infect Dis 2012; 54:1778-83.
37. Crowcroft NS, Rosella LC. The potential effect of temporary immunity as a result of bias associated with healthy users and social determinants on observations of influenza vaccine effectiveness; could unmeasured confounding explain observed links between seasonal influenza vaccine and pandemic H1N1 infection? BMC Public Health 2012; 12:458.
38. Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012; 12:36-44.